Guided Therapeutics (GTHP) Asset Utilization Ratio (2012 - 2026)
Guided Therapeutics (GTHP) posted Asset Utilization Ratio of 0.69 for Q4 2025, up 256.6% sequentially from 0.19 in Q3 2025, and up 12825.2% YoY from N/an in Q4 2024.
Guided Therapeutics (GTHP) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Guided Therapeutics has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.69 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 12825.2% year-over-year to 0.69 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.69 (up 12825.2% YoY) and the FY2025 annual result came in at 0.57, up 12256.19% from the prior year.
- Asset Utilization Ratio climbed to 0.69 in Q4 2025 per GTHP's latest filing, from 0.19 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.69 in Q4 2025 and troughed at 0.0 in Q1 2025.
- A 5-year average of 0.08 and a median of 0.04 in 2022 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 12825.2% in 2025, down 98.36% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.04 in 2021, then sank by 91.61% to 0.0 in 2022, then jumped by 1438.52% to 0.06 in 2023, then sank by 90.36% to 0.01 in 2024, then soared by 12825.2% to 0.69 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.69, 0.19, and 0.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 0.56 |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.61 |
| Dec 31, 2025 | 0.69 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.05 |